DeepTek CXR Analyzer vs PMcardio

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by DeepTek Medical Imaging Pvt
VS
by Powerful Medical

AI Verdict

These tools are adjacent in their focus on cardiology AI but differ significantly in their diagnostic modalities. DeepTek CXR Analyzer specializes in AI-powered chest X-ray analysis for a broad range of pathologies, while PMcardio focuses on AI-driven ECG interpretation for cardiac conditions. Therefore, the choice between them depends on whether the primary need is for X-ray analysis or ECG interpretation.

Choose DeepTek CXR Analyzer if…

Choose DeepTek CXR Analyzer if your radiology department needs an FDA-cleared AI-powered solution to enhance the efficiency and accuracy of chest X-ray interpretations. This tool is ideal for automatically detecting and highlighting suspicious regions across lung, pleural, and cardiac pathologies, significantly reducing radiologist workload and boosting productivity by triaging scans into 'AI Finding-Negative' and 'AI Finding-Positive' categories. It seamlessly integrates with existing PACS, working in the background without altering current workflows, and is compatible with various X-ray modalities.

View DeepTek CXR Analyzer →

Choose PMcardio if…

Choose PMcardio if you require a CE-certified AI platform for rapid and accurate interpretation of ECGs, particularly at the point of care or in emergency settings. This tool is best suited for clinicians, including paramedics and general practitioners, who need to quickly assess over 50 cardiac conditions, including critical ones like STEMI/OMI and reduced LVEF, and receive expert-level interpretations and treatment recommendations to confidently make timely clinical decisions. Its mobile app and web platform deployment options make it highly accessible for various healthcare professionals.

View PMcardio →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature DeepTek CXR Analyzer PMcardio
Pricing Contact sales Freemium
Deployment Cloud; On-premise Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems
FDA Status 1 AI-estimated Pending AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

PMcardio

PMcardio offers deployment as a mobile app and web platform, allowing for instant AI-powered ECG interpretations directly at the point of care, which enhances accessibility and ease of use for a broader range of clinicians. DeepTek CXR Analyzer, while offering seamless PACS integration, is primarily designed for radiologist workflow within an imaging department. PMcardio also features automated ECG digitization from various sources, including smartphone photos of paper printouts, further simplifying its use.

Clinical Value

PMcardio

PMcardio has been clinically validated in over 25 studies and is trusted by over 100,000 clinicians, demonstrating superior accuracy in detecting acute myocardial infarction (OMI) and reducing false STEMI alarms. DeepTek CXR Analyzer is FDA-cleared and aims to reduce radiologist workload by 30-50% and boost productivity, but PMcardio's extensive validation and direct impact on critical cardiac diagnoses at the point of care suggest a broader and more immediate clinical impact.

Pricing & Value

PMcardio

PMcardio offers a freemium model with 5 free ECG analyses per month, making it accessible for individual clinicians to try before committing to a paid plan. DeepTek CXR Analyzer's pricing is 'contact sales' and 'pay-per-use,' which lacks transparency and immediate accessibility for individual users or smaller practices.

Enterprise Readiness

PMcardio

PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, along with configurable user permissions and security protections, indicating a robust solution for health systems. DeepTek CXR Analyzer also offers cloud and on-premise deployment with DICOM-based PACS integration, but PMcardio's comprehensive platform for unified cardiac care across multiple pathways and sites demonstrates a more extensive enterprise-ready offering.

Innovation

PMcardio

PMcardio features 'Queen of Heartsu2122' for STEMI and OMI detection, 'LVsenseu2122' for reduced LVEF detection, and 'ECGxplainu2122' for visual AI explainability with heatmaps, showcasing advanced and transparent AI capabilities. DeepTek CXR Analyzer focuses on computer-assisted detection with automatic highlighting of suspicious regions, which is valuable but PMcardio's explainable AI and specialized detection algorithms represent a higher degree of innovation in diagnostic interpretation.

Support & Docs

Tie

Both tools provide evidence of regulatory compliance (FDA clearance for DeepTek, CE certification and FDA Breakthrough Device Designation for PMcardio) and HIPAA compliance, suggesting a commitment to robust documentation. However, specific details regarding the breadth and accessibility of their support channels or user documentation are not extensively detailed in the provided information for either tool, leading to a tie.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature DeepTek CXR Analyzer PMcardio
Name DeepTek CXR Analyzer PMcardio
Company DeepTek Medical Imaging Pvt Powerful Medical
Description DeepTek CXR Analyzer is an FDA-cleared AI-powered CADe solution for chest X-ray analysis, designed to assist radiologists by automatically detecting and highlighting suspicious regions across lung, pleural, and cardiac pathologies, significantly improving workflow efficiency and diagnostic accuracy. PMcardio is a CE-certified AI platform that interprets ECGs to assess over 50 cardiac conditions rapidly and accurately. Clinically validated in more than 25 studies and trusted by over 100,000 clinicians, it delivers rapid, expert-level interpretations, empowering various healthcare professionals to act with confidence at the point of care.
Regulatory Clearance FDA-cleared CE-certified
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI, Clinical Decision Support & Reference
Specialties Cardiology, Pulmonology, Radiology Cardiology, Emergency Medicine, Internal Medicine
Key Features (Primary Function) AI-Powered Computer-Assisted Detection (CADe) for Chest X-rays; Detection of 28 findings covering lung, pleural, cardiac pathologies, and hardware Instant AI-powered ECG interpretations; Detection of 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders)

Videos

Demos, reviews, and walkthroughs featuring DeepTek CXR Analyzer and PMcardio.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

DeepTek CXR Analyzer integrates seamlessly with existing PACS systems using DICOM, operating in the background without interrupting current workflows. It sends results back to PACS as secondary captures with AI output. PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, connecting to existing ECG systems and communication tools, with governance and role-based access built in. PMcardio can also export detailed PDF diagnostic reports for integration into patients' electronic health records.
DeepTek CXR Analyzer demonstrates high accuracy in detecting suspicious regions across lung, pleural, cardiac pathologies, and hardware on chest X-rays. For detection of ROIs, it shows AUROCs of 0.978 for Cardiac and 0.980 for Hardware, with sensitivities of 0.903 for Lungs and 0.947 for Hardware. PMcardio has been clinically validated in over 25 studies, demonstrating 86% sensitivity and 92% specificity for major ECG abnormalities, and near-perfect accuracy (97% sensitivity and 99% specificity) for atrial fibrillation. It also shows 2x higher sensitivity for early STEMI detection and a 90% reduction in false positives.
DeepTek CXR Analyzer is designed to assist radiologists by automatically detecting and highlighting suspicious regions, suggesting a supportive role rather than a complete replacement of interpretation. DeepTek's solutions are used by over 500 hospitals and imaging centers. PMcardio aims to empower various healthcare professionals with rapid, expert-level interpretations. PMcardio provides email and help desk support for customer questions and issue reporting.
DeepTek CXR Analyzer is reported to reduce radiologist workload by 30-50% and boost productivity by 2x-3x by intelligently segregating scans and highlighting suspicious regions. PMcardio delivers instant AI-powered ECG interpretations, with an average time to diagnosis reduced from 10 to 2.5 seconds. It has also been shown to cut door-to-balloon times by up to 48 minutes and reduce false-positive cath lab activations by over 60%.
PMcardio is built for regulated healthcare environments and supports full audit trails. It is designed for enterprise-ready deployment, connecting to existing systems and scaling across campuses and care settings without custom builds. DeepTek CXR Analyzer sends secondary capture DICOM with AI output to PACS, which would typically be part of a hospital's existing audit trail for imaging. DeepTek's solutions are already used in over 500 hospitals and imaging centers, suggesting experience with multi-site deployments.
PMcardio is certified to industry-leading standards including SOC 2 Type II and ISO 27001, ensuring secure data handling and information security management. It also supports regional data residency and role-based access control. DeepTek CXR Analyzer is FDA-cleared and operates within existing PACS infrastructure, which would typically adhere to the security protocols of the healthcare institution. DeepTek is a venture-funded company incorporated in the United States.
DeepTek CXR Analyzer is a radiology tool focused on chest X-ray analysis, assisting radiologists in detecting 28 findings across lung, pleural, cardiac pathologies, and hardware. It's ideal for specialties like Radiology, Pulmonology, and Cardiology where chest X-rays are a primary diagnostic tool. PMcardio is a cardiology tool focused on ECG interpretation, assessing over 50 cardiac conditions, including STEMI/OMI, rhythms, and reduced LVEF. It's particularly valuable for specialties like Cardiology, Emergency Medicine, and Internal Medicine, especially at the point of care, and offers guideline-adherent treatment recommendations.

Backers

Who funded each tool's parent company.

PMcardio

AI Tool Finder
AI-powered search. Results may not be comprehensive.